The role of molecular pathways in therapeutic response and outcomes in breast cancer

Bookmark and Share
Sorry, this item is currently unavailable.
Published: 8 Nov 2013
Views: 3514
Dr Fabrice André - Institut Gustave Roussy, Villejuif, France

Speaking at the AstraZeneca sponsored satellite symposium 'The revolution in peronalised healthcare: Towards improved outcomes in oncology', at the 2013 European Cancer Congress, Dr Fabrice André covers genomic segmentation of breast cancer and illustrates how drug development in rare genomic segments will occur.